1 | 1 | | HB238INTRODUCED |
---|
2 | 2 | | Page 0 |
---|
3 | 3 | | HB238 |
---|
4 | 4 | | 8JMSH22-1 |
---|
5 | 5 | | By Representative Rigsby |
---|
6 | 6 | | RFD: Insurance |
---|
7 | 7 | | First Read: 27-Feb-24 |
---|
8 | 8 | | 1 |
---|
9 | 9 | | 2 |
---|
10 | 10 | | 3 |
---|
11 | 11 | | 4 |
---|
12 | 12 | | 5 8JMSH22-1 02/21/2024 JC (L)tgw 2023-3818 |
---|
13 | 13 | | Page 1 |
---|
14 | 14 | | First Read: 27-Feb-24 |
---|
15 | 15 | | SYNOPSIS: |
---|
16 | 16 | | Pharmacy benefits managers are third-party |
---|
17 | 17 | | administrators of prescription drug benefits in a |
---|
18 | 18 | | health insurance plan. They are primarily responsible |
---|
19 | 19 | | for processing and paying prescription drug claims. |
---|
20 | 20 | | They typically negotiate price discounts and rebates |
---|
21 | 21 | | from manufacturers and determine how pharmacies get |
---|
22 | 22 | | reimbursed for dispensing prescriptions. Under state |
---|
23 | 23 | | law, pharmacy benefits managers are licensed and |
---|
24 | 24 | | regulated by the Department of Insurance. |
---|
25 | 25 | | This bill would prohibit pharmacy benefits |
---|
26 | 26 | | managers from reimbursing a pharmacy less than the |
---|
27 | 27 | | actual acquisition cost paid by the pharmacy or from |
---|
28 | 28 | | contracting with a health insurer to receive payment |
---|
29 | 29 | | amounts for prescription drug benefits that are |
---|
30 | 30 | | different from the amounts the pharmacy benefits |
---|
31 | 31 | | managers pay pharmacies. This bill would also prohibit |
---|
32 | 32 | | pharmacy benefits manufacturers from starting an |
---|
33 | 33 | | investigation against a pharmacy for fraud, waste, or |
---|
34 | 34 | | abuse without reasonable suspicion. |
---|
35 | 35 | | This bill would further specify the powers that |
---|
36 | 36 | | the Commissioner of Insurance may use to investigate |
---|
37 | 37 | | pharmacy benefits managers and would make pharmacy |
---|
38 | 38 | | benefits managers subject to the Pharmacy Audit |
---|
39 | 39 | | Integrity Act in cases involving fraud, waste, or |
---|
40 | 40 | | 1 |
---|
41 | 41 | | 2 |
---|
42 | 42 | | 3 |
---|
43 | 43 | | 4 |
---|
44 | 44 | | 5 |
---|
45 | 45 | | 6 |
---|
46 | 46 | | 7 |
---|
47 | 47 | | 8 |
---|
48 | 48 | | 9 |
---|
49 | 49 | | 10 |
---|
50 | 50 | | 11 |
---|
51 | 51 | | 12 |
---|
52 | 52 | | 13 |
---|
53 | 53 | | 14 |
---|
54 | 54 | | 15 |
---|
55 | 55 | | 16 |
---|
56 | 56 | | 17 |
---|
57 | 57 | | 18 |
---|
58 | 58 | | 19 |
---|
59 | 59 | | 20 |
---|
60 | 60 | | 21 |
---|
61 | 61 | | 22 |
---|
62 | 62 | | 23 |
---|
63 | 63 | | 24 |
---|
64 | 64 | | 25 |
---|
65 | 65 | | 26 |
---|
66 | 66 | | 27 |
---|
67 | 67 | | 28 HB238 INTRODUCED |
---|
68 | 68 | | Page 2 |
---|
69 | 69 | | Integrity Act in cases involving fraud, waste, or |
---|
70 | 70 | | abuse. |
---|
71 | 71 | | This bill would require pharmacy benefits |
---|
72 | 72 | | managers to pass on 100 percent of the rebates that |
---|
73 | 73 | | they receive from pharmaceutical manufacturers and |
---|
74 | 74 | | would provide reporting requirements on rebates |
---|
75 | 75 | | received by pharmacy benefits managers to both the |
---|
76 | 76 | | commissioner and health insurers. |
---|
77 | 77 | | This bill would also prohibit pharmacy benefits |
---|
78 | 78 | | managers from penalizing health insurers when they |
---|
79 | 79 | | transfer claims processing services and related |
---|
80 | 80 | | functions to a different pharmacy benefits manager. |
---|
81 | 81 | | A BILL |
---|
82 | 82 | | TO BE ENTITLED |
---|
83 | 83 | | AN ACT |
---|
84 | 84 | | Relating to pharmacy benefits managers; to amend |
---|
85 | 85 | | Sections 27-45A-3, 27-45A-4, 27-45A-5, 27-45A-6, 27-45A-7, |
---|
86 | 86 | | 27-45A-8, 27-45A-9, and 27-45A-10, Code of Alabama 1975; to |
---|
87 | 87 | | further provide for regulation of pharmacy benefits managers |
---|
88 | 88 | | in relation to third-party payors and pharmacies; to prohibit |
---|
89 | 89 | | pharmacy benefits managers from paying pharmacies less than |
---|
90 | 90 | | the actual acquisition cost for prescription drugs and from |
---|
91 | 91 | | paying to pharmacies less than the amounts reimbursed by |
---|
92 | 92 | | third-party payors; to permit pharmacists to discuss drug |
---|
93 | 93 | | prices with covered individuals; to prohibit pharmacy benefits |
---|
94 | 94 | | managers from charging pharmacies certain fees or from |
---|
95 | 95 | | 29 |
---|
96 | 96 | | 30 |
---|
97 | 97 | | 31 |
---|
98 | 98 | | 32 |
---|
99 | 99 | | 33 |
---|
100 | 100 | | 34 |
---|
101 | 101 | | 35 |
---|
102 | 102 | | 36 |
---|
103 | 103 | | 37 |
---|
104 | 104 | | 38 |
---|
105 | 105 | | 39 |
---|
106 | 106 | | 40 |
---|
107 | 107 | | 41 |
---|
108 | 108 | | 42 |
---|
109 | 109 | | 43 |
---|
110 | 110 | | 44 |
---|
111 | 111 | | 45 |
---|
112 | 112 | | 46 |
---|
113 | 113 | | 47 |
---|
114 | 114 | | 48 |
---|
115 | 115 | | 49 |
---|
116 | 116 | | 50 |
---|
117 | 117 | | 51 |
---|
118 | 118 | | 52 |
---|
119 | 119 | | 53 |
---|
120 | 120 | | 54 |
---|
121 | 121 | | 55 |
---|
122 | 122 | | 56 HB238 INTRODUCED |
---|
123 | 123 | | Page 3 |
---|
124 | 124 | | managers from charging pharmacies certain fees or from |
---|
125 | 125 | | initiating a fraud, waste, or abuse investigation without |
---|
126 | 126 | | reasonable suspicion; to require pharmacy benefits managers to |
---|
127 | 127 | | report rebate amounts received to the Commissioner of |
---|
128 | 128 | | Insurance and to third-party payors; to provide for |
---|
129 | 129 | | examination of pharmacy benefits managers by the Commissioner |
---|
130 | 130 | | of Insurance; to add Section 27-45A-13 to the Code of Alabama |
---|
131 | 131 | | 1975, to require pharmacy benefits managers to pass on 100 |
---|
132 | 132 | | percent of the rebates received from pharmaceutical |
---|
133 | 133 | | manufacturers to third-party payors and to prohibit pharmacy |
---|
134 | 134 | | benefits managers from penalizing third-party payors for |
---|
135 | 135 | | switching pharmacy benefits managers; and to amend Section |
---|
136 | 136 | | 34-23-187, Code of Alabama 1975, to provide that an |
---|
137 | 137 | | investigation into fraud, waste, or abuse by a pharmacy |
---|
138 | 138 | | benefits manager falls under the Pharmacy Audit Integrity Act. |
---|
139 | 139 | | BE IT ENACTED BY THE LEGISLATURE OF ALABAMA: |
---|
140 | 140 | | Section 1. Sections 27-45A-3, 27-45A-4, 27-45A-5, |
---|
141 | 141 | | 27-45A-6, 27-45A-7, 27-45A-8, 27-45A-9, and 27-45A-10, Code of |
---|
142 | 142 | | Alabama 1975, are amended to read as follows: |
---|
143 | 143 | | "§27-45A-3 |
---|
144 | 144 | | For purposes of this chapter, the following words shall |
---|
145 | 145 | | have the following meanings: |
---|
146 | 146 | | (1) ACTUAL ACQUISITION COST. The Average Acquisition |
---|
147 | 147 | | Cost (AAC) of a drug for the State of Alabama, as published by |
---|
148 | 148 | | the Alabama Medicaid Agency. If no AAC is available, the term |
---|
149 | 149 | | means the wholesale acquisition cost (WAC + 0%). |
---|
150 | 150 | | (2) CLAIMS PROCESSING SERVICES. The administrative |
---|
151 | 151 | | services performed in connection with the processing and |
---|
152 | 152 | | adjudicating of claims relating to pharmacist services that |
---|
153 | 153 | | 57 |
---|
154 | 154 | | 58 |
---|
155 | 155 | | 59 |
---|
156 | 156 | | 60 |
---|
157 | 157 | | 61 |
---|
158 | 158 | | 62 |
---|
159 | 159 | | 63 |
---|
160 | 160 | | 64 |
---|
161 | 161 | | 65 |
---|
162 | 162 | | 66 |
---|
163 | 163 | | 67 |
---|
164 | 164 | | 68 |
---|
165 | 165 | | 69 |
---|
166 | 166 | | 70 |
---|
167 | 167 | | 71 |
---|
168 | 168 | | 72 |
---|
169 | 169 | | 73 |
---|
170 | 170 | | 74 |
---|
171 | 171 | | 75 |
---|
172 | 172 | | 76 |
---|
173 | 173 | | 77 |
---|
174 | 174 | | 78 |
---|
175 | 175 | | 79 |
---|
176 | 176 | | 80 |
---|
177 | 177 | | 81 |
---|
178 | 178 | | 82 |
---|
179 | 179 | | 83 |
---|
180 | 180 | | 84 HB238 INTRODUCED |
---|
181 | 181 | | Page 4 |
---|
182 | 182 | | adjudicating of claims relating to pharmacist services that |
---|
183 | 183 | | include any of the following: |
---|
184 | 184 | | a. Receiving payments for pharmacist services. |
---|
185 | 185 | | b. Making payments to pharmacists or pharmacies for |
---|
186 | 186 | | pharmacist services. |
---|
187 | 187 | | c. Both paragraphs a. and b. |
---|
188 | 188 | | (2)(3) COVERED INDIVIDUAL. A member, policyholder, |
---|
189 | 189 | | subscriber, enrollee, beneficiary, dependent, or other |
---|
190 | 190 | | individual participating in a health benefit plan. |
---|
191 | 191 | | (3)(4) HEALTH BENEFIT PLAN. A policy, contract, |
---|
192 | 192 | | certificate, or agreement entered into, offered, or issued by |
---|
193 | 193 | | a payor or health insurer to provide, deliver, arrange for, |
---|
194 | 194 | | pay for, or reimburse any of the costs of physical, mental, or |
---|
195 | 195 | | behavioral health care services , including pharmacist |
---|
196 | 196 | | services. |
---|
197 | 197 | | (4)(5) HEALTH INSURER. An entity subject to the |
---|
198 | 198 | | insurance laws of this state and rules of the department, or |
---|
199 | 199 | | subject to the jurisdiction of the department, that contracts |
---|
200 | 200 | | or offers to contract to provide, deliver, arrange for, pay |
---|
201 | 201 | | for, or reimburse any of the costs of health care services, |
---|
202 | 202 | | including, but not limited to, a sickness and accident |
---|
203 | 203 | | insurance company, a health maintenance organization operating |
---|
204 | 204 | | pursuant to Chapter 21A, a nonprofit hospital or health |
---|
205 | 205 | | service corporation, a health care service plan organized |
---|
206 | 206 | | pursuant to Article 6, Chapter 20 of Title 10A, or any other |
---|
207 | 207 | | entity providing a plan of health insurance, health benefits, |
---|
208 | 208 | | or health services. |
---|
209 | 209 | | (6) IN-NETWORK or NETWORK. A network of pharmacists or |
---|
210 | 210 | | pharmacies that are paid for pharmacist services pursuant to |
---|
211 | 211 | | 85 |
---|
212 | 212 | | 86 |
---|
213 | 213 | | 87 |
---|
214 | 214 | | 88 |
---|
215 | 215 | | 89 |
---|
216 | 216 | | 90 |
---|
217 | 217 | | 91 |
---|
218 | 218 | | 92 |
---|
219 | 219 | | 93 |
---|
220 | 220 | | 94 |
---|
221 | 221 | | 95 |
---|
222 | 222 | | 96 |
---|
223 | 223 | | 97 |
---|
224 | 224 | | 98 |
---|
225 | 225 | | 99 |
---|
226 | 226 | | 100 |
---|
227 | 227 | | 101 |
---|
228 | 228 | | 102 |
---|
229 | 229 | | 103 |
---|
230 | 230 | | 104 |
---|
231 | 231 | | 105 |
---|
232 | 232 | | 106 |
---|
233 | 233 | | 107 |
---|
234 | 234 | | 108 |
---|
235 | 235 | | 109 |
---|
236 | 236 | | 110 |
---|
237 | 237 | | 111 |
---|
238 | 238 | | 112 HB238 INTRODUCED |
---|
239 | 239 | | Page 5 |
---|
240 | 240 | | pharmacies that are paid for pharmacist services pursuant to |
---|
241 | 241 | | an agreement with a health benefit plan or a pharmacy benefits |
---|
242 | 242 | | manager. |
---|
243 | 243 | | (5)(7) OTHER PRESCRIPTION DRUG OR DEVICE SERVICES. |
---|
244 | 244 | | Services, other than claims processing services, provided |
---|
245 | 245 | | directly or indirectly, whether in connection with or separate |
---|
246 | 246 | | from claims processing services, including, but not limited |
---|
247 | 247 | | to, any of the following: |
---|
248 | 248 | | a. Negotiating rebates , discounts, or other financial |
---|
249 | 249 | | incentives and arrangements with drug companies. |
---|
250 | 250 | | b. Disbursing or distributing rebates. |
---|
251 | 251 | | c. Managing or participating in incentive programs or |
---|
252 | 252 | | arrangements for pharmacist services. |
---|
253 | 253 | | d. Negotiating or entering into contractual |
---|
254 | 254 | | arrangements with pharmacists or pharmacies, or both. |
---|
255 | 255 | | e. Developing formularies. |
---|
256 | 256 | | f. Designing prescription benefit programs. |
---|
257 | 257 | | g. Advertising or promoting services. |
---|
258 | 258 | | (8) PAYOR. Any entity other than a health insurer |
---|
259 | 259 | | involved in the financing or payment of pharmacist services. |
---|
260 | 260 | | (9) PBM AFFILIATE. An entity, including, but not |
---|
261 | 261 | | limited to, a pharmacy, health insurer, or group purchasing |
---|
262 | 262 | | organization that directly or indirectly, through one or more |
---|
263 | 263 | | intermediaries, has one of the following affiliations: |
---|
264 | 264 | | a. Owns, controls, or has an investment interest in a |
---|
265 | 265 | | pharmacy benefits manager. |
---|
266 | 266 | | b. Is owned, controlled by, or has an investment |
---|
267 | 267 | | interest holder who is a pharmacy benefits manager. |
---|
268 | 268 | | c. Is under common ownership or corporate control with |
---|
269 | 269 | | 113 |
---|
270 | 270 | | 114 |
---|
271 | 271 | | 115 |
---|
272 | 272 | | 116 |
---|
273 | 273 | | 117 |
---|
274 | 274 | | 118 |
---|
275 | 275 | | 119 |
---|
276 | 276 | | 120 |
---|
277 | 277 | | 121 |
---|
278 | 278 | | 122 |
---|
279 | 279 | | 123 |
---|
280 | 280 | | 124 |
---|
281 | 281 | | 125 |
---|
282 | 282 | | 126 |
---|
283 | 283 | | 127 |
---|
284 | 284 | | 128 |
---|
285 | 285 | | 129 |
---|
286 | 286 | | 130 |
---|
287 | 287 | | 131 |
---|
288 | 288 | | 132 |
---|
289 | 289 | | 133 |
---|
290 | 290 | | 134 |
---|
291 | 291 | | 135 |
---|
292 | 292 | | 136 |
---|
293 | 293 | | 137 |
---|
294 | 294 | | 138 |
---|
295 | 295 | | 139 |
---|
296 | 296 | | 140 HB238 INTRODUCED |
---|
297 | 297 | | Page 6 |
---|
298 | 298 | | c. Is under common ownership or corporate control with |
---|
299 | 299 | | a pharmacy benefits manager. |
---|
300 | 300 | | (6)(10) PHARMACIST. As defined in Section 34-23-1. |
---|
301 | 301 | | (7)(11) PHARMACIST SERVICES. Products, goods, and |
---|
302 | 302 | | services, or any combination of products, goods, and services, |
---|
303 | 303 | | provided as a part of the practice of pharmacy. |
---|
304 | 304 | | (8)(12) PHARMACY. As defined in Section 34-23-1. |
---|
305 | 305 | | (9)(13) PHARMACY BENEFITS MANAGER. a. A person, |
---|
306 | 306 | | including a wholly or partially owned or controlled subsidiary |
---|
307 | 307 | | of a pharmacy benefits manager, that provides claims |
---|
308 | 308 | | processing services or other prescription drug or device |
---|
309 | 309 | | services, or both, to covered individuals who are employed in |
---|
310 | 310 | | or are residents of this state, for health benefit plans. The |
---|
311 | 311 | | term includes any person that administers a prescription |
---|
312 | 312 | | discount program directly or on behalf of a pharmacy benefits |
---|
313 | 313 | | manager or health benefit plan for drugs to covered |
---|
314 | 314 | | individuals which are not reimbursed by a pharmacy benefits |
---|
315 | 315 | | manager or are not covered by a health benefit plan. |
---|
316 | 316 | | b. Pharmacy benefits manager does not include any of |
---|
317 | 317 | | the following: |
---|
318 | 318 | | 1. A healthcare health care facility licensed in this |
---|
319 | 319 | | state. |
---|
320 | 320 | | 2. A healthcare health care professional licensed in |
---|
321 | 321 | | this state. |
---|
322 | 322 | | 3. A consultant who only provides advice as to the |
---|
323 | 323 | | selection or performance of a pharmacy benefits manager. |
---|
324 | 324 | | (10) PBM AFFILIATE. A pharmacy or pharmacist that, |
---|
325 | 325 | | directly or indirectly, through one or more intermediaries, is |
---|
326 | 326 | | owned or controlled by, or is under common control by, a |
---|
327 | 327 | | 141 |
---|
328 | 328 | | 142 |
---|
329 | 329 | | 143 |
---|
330 | 330 | | 144 |
---|
331 | 331 | | 145 |
---|
332 | 332 | | 146 |
---|
333 | 333 | | 147 |
---|
334 | 334 | | 148 |
---|
335 | 335 | | 149 |
---|
336 | 336 | | 150 |
---|
337 | 337 | | 151 |
---|
338 | 338 | | 152 |
---|
339 | 339 | | 153 |
---|
340 | 340 | | 154 |
---|
341 | 341 | | 155 |
---|
342 | 342 | | 156 |
---|
343 | 343 | | 157 |
---|
344 | 344 | | 158 |
---|
345 | 345 | | 159 |
---|
346 | 346 | | 160 |
---|
347 | 347 | | 161 |
---|
348 | 348 | | 162 |
---|
349 | 349 | | 163 |
---|
350 | 350 | | 164 |
---|
351 | 351 | | 165 |
---|
352 | 352 | | 166 |
---|
353 | 353 | | 167 |
---|
354 | 354 | | 168 HB238 INTRODUCED |
---|
355 | 355 | | Page 7 |
---|
356 | 356 | | owned or controlled by, or is under common control by, a |
---|
357 | 357 | | pharmacy benefits manager. |
---|
358 | 358 | | (14) PRESCRIPTION DRUG FILE. Any electronic and |
---|
359 | 359 | | computer data files maintained by a pharmacy benefits manager |
---|
360 | 360 | | in connection with administering prescription drug benefits on |
---|
361 | 361 | | behalf of a health benefit plan, including, but not limited |
---|
362 | 362 | | to, claims history files, drug utilization review files, prior |
---|
363 | 363 | | authorization files, EDI 834 eligibility files, accumulator |
---|
364 | 364 | | files, step therapy files, and other records pertaining to |
---|
365 | 365 | | covered individuals. |
---|
366 | 366 | | (11)(15) PRESCRIPTION DRUGS. Includes, but is not |
---|
367 | 367 | | limited to, certain infusion, compounded, and long-term care, |
---|
368 | 368 | | and specialty prescription drugs . The term does not include |
---|
369 | 369 | | specialty drugs. |
---|
370 | 370 | | (16) REBATE. Any payments or price concessions that |
---|
371 | 371 | | accrue to a pharmacy benefits manager or its health benefit |
---|
372 | 372 | | plan client, directly or indirectly, including through its PBM |
---|
373 | 373 | | affiliate or its subsidiary, third party, or intermediary, |
---|
374 | 374 | | including an off-shore group purchasing organization, from a |
---|
375 | 375 | | pharmaceutical manufacturer or its affiliate, subsidiary, |
---|
376 | 376 | | third party, or intermediary. The term includes, but is not |
---|
377 | 377 | | limited to, payments, discounts, administration fees, credits, |
---|
378 | 378 | | incentives, or penalties associated, directly or indirectly, |
---|
379 | 379 | | in any way with claims administered on behalf of a health |
---|
380 | 380 | | benefit plan. |
---|
381 | 381 | | (12)(17) SPECIALTY DRUGS. Prescription medications that |
---|
382 | 382 | | require special handling, administration, or monitoring and |
---|
383 | 383 | | are used for the treatment of patients with serious health |
---|
384 | 384 | | conditions requiring complex therapies, and that are eligible |
---|
385 | 385 | | 169 |
---|
386 | 386 | | 170 |
---|
387 | 387 | | 171 |
---|
388 | 388 | | 172 |
---|
389 | 389 | | 173 |
---|
390 | 390 | | 174 |
---|
391 | 391 | | 175 |
---|
392 | 392 | | 176 |
---|
393 | 393 | | 177 |
---|
394 | 394 | | 178 |
---|
395 | 395 | | 179 |
---|
396 | 396 | | 180 |
---|
397 | 397 | | 181 |
---|
398 | 398 | | 182 |
---|
399 | 399 | | 183 |
---|
400 | 400 | | 184 |
---|
401 | 401 | | 185 |
---|
402 | 402 | | 186 |
---|
403 | 403 | | 187 |
---|
404 | 404 | | 188 |
---|
405 | 405 | | 189 |
---|
406 | 406 | | 190 |
---|
407 | 407 | | 191 |
---|
408 | 408 | | 192 |
---|
409 | 409 | | 193 |
---|
410 | 410 | | 194 |
---|
411 | 411 | | 195 |
---|
412 | 412 | | 196 HB238 INTRODUCED |
---|
413 | 413 | | Page 8 |
---|
414 | 414 | | conditions requiring complex therapies, and that are eligible |
---|
415 | 415 | | for specialty tier placement by the Centers for Medicare and |
---|
416 | 416 | | Medicaid Services pursuant to 42 C.F.R. § 423.560. |
---|
417 | 417 | | (18) SPREAD PRICING. A prescription drug pricing model |
---|
418 | 418 | | used by a pharmacy benefits manager in which the pharmacy |
---|
419 | 419 | | benefits manager charges a health benefit plan a contracted |
---|
420 | 420 | | price for prescription drugs that differs from the amount the |
---|
421 | 421 | | pharmacy benefits manager pays the pharmacy for the |
---|
422 | 422 | | prescription drug, including any post-sale or |
---|
423 | 423 | | post-adjudication fees, discounts, or adjustments where not |
---|
424 | 424 | | prohibited by law. " |
---|
425 | 425 | | "§27-45A-4 |
---|
426 | 426 | | (a) A person may not establish or operate as a pharmacy |
---|
427 | 427 | | benefits manager in this state without first obtaining a |
---|
428 | 428 | | license from the commissioner. |
---|
429 | 429 | | (b) Effective through December 31, 2021, to initially |
---|
430 | 430 | | obtain a license or renew a license, a pharmacy benefits |
---|
431 | 431 | | manager shall submit all of the following: |
---|
432 | 432 | | (1) A nonrefundable fee not to exceed five hundred |
---|
433 | 433 | | dollars ($500). |
---|
434 | 434 | | (2) A copy of the licensee's corporate charter, |
---|
435 | 435 | | articles of incorporation, or other charter document. |
---|
436 | 436 | | (3) A completed licensure form adopted by the |
---|
437 | 437 | | commissioner containing: |
---|
438 | 438 | | a. The name and address of the licensee. |
---|
439 | 439 | | b. The name, address, and official position of an |
---|
440 | 440 | | employee who will serve as the primary contact for the |
---|
441 | 441 | | Department of Insurance. |
---|
442 | 442 | | c. Any additional contact information deemed |
---|
443 | 443 | | 197 |
---|
444 | 444 | | 198 |
---|
445 | 445 | | 199 |
---|
446 | 446 | | 200 |
---|
447 | 447 | | 201 |
---|
448 | 448 | | 202 |
---|
449 | 449 | | 203 |
---|
450 | 450 | | 204 |
---|
451 | 451 | | 205 |
---|
452 | 452 | | 206 |
---|
453 | 453 | | 207 |
---|
454 | 454 | | 208 |
---|
455 | 455 | | 209 |
---|
456 | 456 | | 210 |
---|
457 | 457 | | 211 |
---|
458 | 458 | | 212 |
---|
459 | 459 | | 213 |
---|
460 | 460 | | 214 |
---|
461 | 461 | | 215 |
---|
462 | 462 | | 216 |
---|
463 | 463 | | 217 |
---|
464 | 464 | | 218 |
---|
465 | 465 | | 219 |
---|
466 | 466 | | 220 |
---|
467 | 467 | | 221 |
---|
468 | 468 | | 222 |
---|
469 | 469 | | 223 |
---|
470 | 470 | | 224 HB238 INTRODUCED |
---|
471 | 471 | | Page 9 |
---|
472 | 472 | | c. Any additional contact information deemed |
---|
473 | 473 | | appropriate by the commissioner or reasonably necessary to |
---|
474 | 474 | | verify the information contained in the application. |
---|
475 | 475 | | (c) Not later than January 1, 2022, the commissioner |
---|
476 | 476 | | shall adopt rules for licensure of pharmacy benefits managers |
---|
477 | 477 | | to operate in this state. The rules shall establish all of the |
---|
478 | 478 | | following: |
---|
479 | 479 | | (1) The licensing procedure and application form. |
---|
480 | 480 | | (2) Requirements for licensure. |
---|
481 | 481 | | (3) Reporting requirements. |
---|
482 | 482 | | (4) A fee schedule for a nonrefundable application fee |
---|
483 | 483 | | and a nonrefundable license renewal fee, set to allow the |
---|
484 | 484 | | regulation and oversight activities of the department to be |
---|
485 | 485 | | self-supporting. |
---|
486 | 486 | | (d) On and after January 1, 2022, a person applying for |
---|
487 | 487 | | a pharmacy benefits manager license shall submit an |
---|
488 | 488 | | application for licensure in the form and manner prescribed by |
---|
489 | 489 | | the commissioner by rule, along with the application fee. |
---|
490 | 490 | | (e) The commissioner may refuse to issue or renew a |
---|
491 | 491 | | license if the commissioner determines that the applicant has |
---|
492 | 492 | | been found to have violated this chapter , Article 8 of Chapter |
---|
493 | 493 | | 23 of Title 34, or the insurance laws of this state or any |
---|
494 | 494 | | other jurisdiction, or has had an insurance or other |
---|
495 | 495 | | certificate of authority or license denied or revoked for |
---|
496 | 496 | | cause by any jurisdiction. |
---|
497 | 497 | | (f) Unless denied licensure pursuant to subsection (e), |
---|
498 | 498 | | a person who meets the requirements of this chapter and rules |
---|
499 | 499 | | adopted by the commissioner shall be issued a pharmacy |
---|
500 | 500 | | benefits manager license. The license may be in paper or |
---|
501 | 501 | | 225 |
---|
502 | 502 | | 226 |
---|
503 | 503 | | 227 |
---|
504 | 504 | | 228 |
---|
505 | 505 | | 229 |
---|
506 | 506 | | 230 |
---|
507 | 507 | | 231 |
---|
508 | 508 | | 232 |
---|
509 | 509 | | 233 |
---|
510 | 510 | | 234 |
---|
511 | 511 | | 235 |
---|
512 | 512 | | 236 |
---|
513 | 513 | | 237 |
---|
514 | 514 | | 238 |
---|
515 | 515 | | 239 |
---|
516 | 516 | | 240 |
---|
517 | 517 | | 241 |
---|
518 | 518 | | 242 |
---|
519 | 519 | | 243 |
---|
520 | 520 | | 244 |
---|
521 | 521 | | 245 |
---|
522 | 522 | | 246 |
---|
523 | 523 | | 247 |
---|
524 | 524 | | 248 |
---|
525 | 525 | | 249 |
---|
526 | 526 | | 250 |
---|
527 | 527 | | 251 |
---|
528 | 528 | | 252 HB238 INTRODUCED |
---|
529 | 529 | | Page 10 |
---|
530 | 530 | | benefits manager license. The license may be in paper or |
---|
531 | 531 | | electronic form and shall clearly indicate the expiration date |
---|
532 | 532 | | of the license. Licenses are nontransferable. Notwithstanding |
---|
533 | 533 | | any provision of law to the contrary, the application and |
---|
534 | 534 | | license shall be public records. |
---|
535 | 535 | | (g) The license shall be initially renewed in |
---|
536 | 536 | | accordance with a schedule prescribed by the commissioner and |
---|
537 | 537 | | shall thereafter be subject to renewal on an annual basis |
---|
538 | 538 | | along with the nonrefundable license renewal fee. |
---|
539 | 539 | | (h) A licensee shall inform the commissioner by any |
---|
540 | 540 | | means acceptable to the commissioner of any material change in |
---|
541 | 541 | | the information required by this section or rules adopted |
---|
542 | 542 | | pursuant to this section within 30 days of the change. Failure |
---|
543 | 543 | | to timely inform the commissioner of a change shall result in |
---|
544 | 544 | | a penalty against the licensee in the amount of fifty dollars |
---|
545 | 545 | | ($50). |
---|
546 | 546 | | (i) The commissioner may suspend or revoke a license or |
---|
547 | 547 | | may impose civil penalties for a violation of this chapter , |
---|
548 | 548 | | Article 8 of Chapter 23 of Title 34, or the insurance laws of |
---|
549 | 549 | | this state or any other jurisdiction, as determined by the |
---|
550 | 550 | | commissioner in accordance with rules adopted by the |
---|
551 | 551 | | commissioner, provided a pharmacy benefits manager shall have |
---|
552 | 552 | | the same rights as insurers to request a hearing in accordance |
---|
553 | 553 | | with Sections 27-2-28, et seq. , and to appeal as provided in |
---|
554 | 554 | | Section 27-2-32. |
---|
555 | 555 | | (j) Unless surrendered, suspended, or revoked by the |
---|
556 | 556 | | commissioner, a license issued under this section shall remain |
---|
557 | 557 | | valid as long as the pharmacy benefits manager continues to do |
---|
558 | 558 | | business in this state and remains in compliance with this |
---|
559 | 559 | | 253 |
---|
560 | 560 | | 254 |
---|
561 | 561 | | 255 |
---|
562 | 562 | | 256 |
---|
563 | 563 | | 257 |
---|
564 | 564 | | 258 |
---|
565 | 565 | | 259 |
---|
566 | 566 | | 260 |
---|
567 | 567 | | 261 |
---|
568 | 568 | | 262 |
---|
569 | 569 | | 263 |
---|
570 | 570 | | 264 |
---|
571 | 571 | | 265 |
---|
572 | 572 | | 266 |
---|
573 | 573 | | 267 |
---|
574 | 574 | | 268 |
---|
575 | 575 | | 269 |
---|
576 | 576 | | 270 |
---|
577 | 577 | | 271 |
---|
578 | 578 | | 272 |
---|
579 | 579 | | 273 |
---|
580 | 580 | | 274 |
---|
581 | 581 | | 275 |
---|
582 | 582 | | 276 |
---|
583 | 583 | | 277 |
---|
584 | 584 | | 278 |
---|
585 | 585 | | 279 |
---|
586 | 586 | | 280 HB238 INTRODUCED |
---|
587 | 587 | | Page 11 |
---|
588 | 588 | | business in this state and remains in compliance with this |
---|
589 | 589 | | chapter and applicable rules, including the payment of an |
---|
590 | 590 | | annual license renewal fee as set forth in subsection (g). |
---|
591 | 591 | | (k) All documents, materials, or other information, and |
---|
592 | 592 | | copies thereof, in the possession or control of the department |
---|
593 | 593 | | that are obtained by or disclosed to the commissioner or any |
---|
594 | 594 | | other person in the course of an application, examination, or |
---|
595 | 595 | | investigation made pursuant to this chapter shall be |
---|
596 | 596 | | confidential by law and privileged, shall not be subject to |
---|
597 | 597 | | any open records, freedom of information, sunshine, or other |
---|
598 | 598 | | public record disclosure laws, and shall not be subject to |
---|
599 | 599 | | subpoena or discovery. This subdivision subsection only |
---|
600 | 600 | | applies to disclosure of confidential documents by the |
---|
601 | 601 | | department and does not create any privilege in favor of any |
---|
602 | 602 | | other party. |
---|
603 | 603 | | (l)(1) Fees collected pursuant to this section shall be |
---|
604 | 604 | | deposited in the State Treasury to the credit of the Insurance |
---|
605 | 605 | | Department Fund. |
---|
606 | 606 | | (2) Civil penalties collected pursuant to this chapter |
---|
607 | 607 | | shall be deposited in the State Treasury to the credit of the |
---|
608 | 608 | | state State General Fund. |
---|
609 | 609 | | (m) Commencing January 1, 2022, a pharmacy benefits |
---|
610 | 610 | | manager licensed by the commissioner prior to January 1, 2022, |
---|
611 | 611 | | shall submit an application for a new license in accordance |
---|
612 | 612 | | with subsection (d). The pharmacy benefits manager's previous |
---|
613 | 613 | | license shall expire on the date the commissioner issues a new |
---|
614 | 614 | | license or April 1, 2022, whichever occurs earlier." |
---|
615 | 615 | | "§27-45A-5 |
---|
616 | 616 | | (a) The commissioner may adopt rules necessary to |
---|
617 | 617 | | 281 |
---|
618 | 618 | | 282 |
---|
619 | 619 | | 283 |
---|
620 | 620 | | 284 |
---|
621 | 621 | | 285 |
---|
622 | 622 | | 286 |
---|
623 | 623 | | 287 |
---|
624 | 624 | | 288 |
---|
625 | 625 | | 289 |
---|
626 | 626 | | 290 |
---|
627 | 627 | | 291 |
---|
628 | 628 | | 292 |
---|
629 | 629 | | 293 |
---|
630 | 630 | | 294 |
---|
631 | 631 | | 295 |
---|
632 | 632 | | 296 |
---|
633 | 633 | | 297 |
---|
634 | 634 | | 298 |
---|
635 | 635 | | 299 |
---|
636 | 636 | | 300 |
---|
637 | 637 | | 301 |
---|
638 | 638 | | 302 |
---|
639 | 639 | | 303 |
---|
640 | 640 | | 304 |
---|
641 | 641 | | 305 |
---|
642 | 642 | | 306 |
---|
643 | 643 | | 307 |
---|
644 | 644 | | 308 HB238 INTRODUCED |
---|
645 | 645 | | Page 12 |
---|
646 | 646 | | (a) The commissioner may adopt rules necessary to |
---|
647 | 647 | | implement this chapter and Article 8 of Chapter 23 of Title |
---|
648 | 648 | | 34. |
---|
649 | 649 | | (b) The powers and duties set forth in this chapter |
---|
650 | 650 | | shall be in addition to all other authority of the |
---|
651 | 651 | | commissioner. |
---|
652 | 652 | | (c) The commissioner shall enforce compliance with the |
---|
653 | 653 | | requirements of this chapter and rules adopted thereunder. |
---|
654 | 654 | | (d) The commissioner shall require the pharmacy |
---|
655 | 655 | | benefits manager to submit a report for each health insurer, |
---|
656 | 656 | | on a periodic basis, which may include, but not be limited to, |
---|
657 | 657 | | the following information: |
---|
658 | 658 | | (1) The aggregate amount of rebates received by the |
---|
659 | 659 | | pharmacy benefits manager. |
---|
660 | 660 | | (2) The aggregate amount of rebates distributed to the |
---|
661 | 661 | | health insurer. |
---|
662 | 662 | | (3) The aggregate amount of rebates the health insurer |
---|
663 | 663 | | passed on to the insurer's covered individuals which reduced |
---|
664 | 664 | | applicable cost-sharing amounts at the point-of-sale, |
---|
665 | 665 | | including deductibles, copayments, and coinsurance. |
---|
666 | 666 | | (4) The aggregate amount paid to the pharmacy benefits |
---|
667 | 667 | | manager for pharmacist services in categories for pharmacy, |
---|
668 | 668 | | drug product, medical devices, and other products, goods, or |
---|
669 | 669 | | services. |
---|
670 | 670 | | (5) The aggregate amount paid to a pharmacy for |
---|
671 | 671 | | pharmacist services in categories for drug product, medical |
---|
672 | 672 | | devices, and other products, goods, or services. |
---|
673 | 673 | | (d)(e)(1) The commissioner may examine or audit any |
---|
674 | 674 | | books and records of a pharmacy benefits manager providing |
---|
675 | 675 | | 309 |
---|
676 | 676 | | 310 |
---|
677 | 677 | | 311 |
---|
678 | 678 | | 312 |
---|
679 | 679 | | 313 |
---|
680 | 680 | | 314 |
---|
681 | 681 | | 315 |
---|
682 | 682 | | 316 |
---|
683 | 683 | | 317 |
---|
684 | 684 | | 318 |
---|
685 | 685 | | 319 |
---|
686 | 686 | | 320 |
---|
687 | 687 | | 321 |
---|
688 | 688 | | 322 |
---|
689 | 689 | | 323 |
---|
690 | 690 | | 324 |
---|
691 | 691 | | 325 |
---|
692 | 692 | | 326 |
---|
693 | 693 | | 327 |
---|
694 | 694 | | 328 |
---|
695 | 695 | | 329 |
---|
696 | 696 | | 330 |
---|
697 | 697 | | 331 |
---|
698 | 698 | | 332 |
---|
699 | 699 | | 333 |
---|
700 | 700 | | 334 |
---|
701 | 701 | | 335 |
---|
702 | 702 | | 336 HB238 INTRODUCED |
---|
703 | 703 | | Page 13 |
---|
704 | 704 | | books and records of a pharmacy benefits manager providing |
---|
705 | 705 | | claims processing services or other prescription drug or |
---|
706 | 706 | | device services for a health benefit plan as may be deemed |
---|
707 | 707 | | relevant and necessary by the commissioner to determine |
---|
708 | 708 | | compliance with this chapter. |
---|
709 | 709 | | (2) Examinations conducted by the commissioner shall be |
---|
710 | 710 | | pursuant to the same examination authority of the commissioner |
---|
711 | 711 | | relative to insurers as provided in Chapter 2, including, but |
---|
712 | 712 | | not limited to, the confidentiality of documents and |
---|
713 | 713 | | information submitted as provided in Section 27-2-24; |
---|
714 | 714 | | examination expenses shall be processed in accordance with |
---|
715 | 715 | | Section 27-2-25; and pharmacy benefits managers shall have the |
---|
716 | 716 | | same rights as insurers to request a hearing in accordance |
---|
717 | 717 | | with Sections 27-2-28 , et seq., and to appeal as provided in |
---|
718 | 718 | | Section 27-2-32. |
---|
719 | 719 | | (3) Any examination or audit by the commissioner may |
---|
720 | 720 | | include production by the pharmacy benefits manager of the |
---|
721 | 721 | | following: |
---|
722 | 722 | | a. Contracts with any pharmaceutical manufacturers, |
---|
723 | 723 | | health insurers, payors, and pharmacies. |
---|
724 | 724 | | b. Data on plan utilization, plan pricing, pharmacy |
---|
725 | 725 | | utilization, and pharmacy pricing. |
---|
726 | 726 | | c. Documents created pursuant to network development, |
---|
727 | 727 | | including contract negotiations, and decisions on network |
---|
728 | 728 | | membership. |
---|
729 | 729 | | (e)(f) The commissioner's examination expenses shall be |
---|
730 | 730 | | collected from pharmacy benefits managers in the same manner |
---|
731 | 731 | | as those collected from insurers." |
---|
732 | 732 | | "§27-45A-6 |
---|
733 | 733 | | 337 |
---|
734 | 734 | | 338 |
---|
735 | 735 | | 339 |
---|
736 | 736 | | 340 |
---|
737 | 737 | | 341 |
---|
738 | 738 | | 342 |
---|
739 | 739 | | 343 |
---|
740 | 740 | | 344 |
---|
741 | 741 | | 345 |
---|
742 | 742 | | 346 |
---|
743 | 743 | | 347 |
---|
744 | 744 | | 348 |
---|
745 | 745 | | 349 |
---|
746 | 746 | | 350 |
---|
747 | 747 | | 351 |
---|
748 | 748 | | 352 |
---|
749 | 749 | | 353 |
---|
750 | 750 | | 354 |
---|
751 | 751 | | 355 |
---|
752 | 752 | | 356 |
---|
753 | 753 | | 357 |
---|
754 | 754 | | 358 |
---|
755 | 755 | | 359 |
---|
756 | 756 | | 360 |
---|
757 | 757 | | 361 |
---|
758 | 758 | | 362 |
---|
759 | 759 | | 363 |
---|
760 | 760 | | 364 HB238 INTRODUCED |
---|
761 | 761 | | Page 14 |
---|
762 | 762 | | "§27-45A-6 |
---|
763 | 763 | | (a) Nothing in this chapter is intended or shall be |
---|
764 | 764 | | construed to do any either of the following: |
---|
765 | 765 | | (1) Be in conflict with existing relevant federal law. |
---|
766 | 766 | | (2) Apply to any specialty drug. |
---|
767 | 767 | | (3)(2) Impact the ability of a hospital to mandate its |
---|
768 | 768 | | employees' use of a hospital-owned pharmacy. |
---|
769 | 769 | | (b) The following provisions shall not apply to the |
---|
770 | 770 | | administration by a person of any term, including prescription |
---|
771 | 771 | | drug benefits, of a self-funded health benefit plan that is |
---|
772 | 772 | | governed by the federal Employee Retirement Income Security |
---|
773 | 773 | | Act of 1974, 29 U.S.C. §1001 et. seq.: |
---|
774 | 774 | | (1) Subdivisions (1) and (5) of Section 27-45A-8. |
---|
775 | 775 | | (2) Subdivisions (2), (3), (6), and (7) of Section |
---|
776 | 776 | | 27-45A-10." |
---|
777 | 777 | | "§27-45A-7 |
---|
778 | 778 | | Reserved.(a) A pharmacy benefits manager shall do all |
---|
779 | 779 | | of the following: |
---|
780 | 780 | | (1) Designate the pharmacy benefits manager's point of |
---|
781 | 781 | | contact for any in-network pharmacist and pharmacy. |
---|
782 | 782 | | (2) Respond to a request from an in-network pharmacist |
---|
783 | 783 | | or pharmacy within two business days. |
---|
784 | 784 | | (b) A pharmacy benefits manager may establish a process |
---|
785 | 785 | | whereby a pharmacist or pharmacy may appeal a reimbursement |
---|
786 | 786 | | decision that fails to pay the actual acquisition cost for any |
---|
787 | 787 | | prescription drug or device, provided that nothing herein |
---|
788 | 788 | | shall be construed to prohibit a pharmacy from filing a |
---|
789 | 789 | | complaint with the commissioner if the pharmacy is not |
---|
790 | 790 | | reimbursed in accordance with Section 27-45A-10. " |
---|
791 | 791 | | 365 |
---|
792 | 792 | | 366 |
---|
793 | 793 | | 367 |
---|
794 | 794 | | 368 |
---|
795 | 795 | | 369 |
---|
796 | 796 | | 370 |
---|
797 | 797 | | 371 |
---|
798 | 798 | | 372 |
---|
799 | 799 | | 373 |
---|
800 | 800 | | 374 |
---|
801 | 801 | | 375 |
---|
802 | 802 | | 376 |
---|
803 | 803 | | 377 |
---|
804 | 804 | | 378 |
---|
805 | 805 | | 379 |
---|
806 | 806 | | 380 |
---|
807 | 807 | | 381 |
---|
808 | 808 | | 382 |
---|
809 | 809 | | 383 |
---|
810 | 810 | | 384 |
---|
811 | 811 | | 385 |
---|
812 | 812 | | 386 |
---|
813 | 813 | | 387 |
---|
814 | 814 | | 388 |
---|
815 | 815 | | 389 |
---|
816 | 816 | | 390 |
---|
817 | 817 | | 391 |
---|
818 | 818 | | 392 HB238 INTRODUCED |
---|
819 | 819 | | Page 15 |
---|
820 | 820 | | reimbursed in accordance with Section 27-45A-10. " |
---|
821 | 821 | | "§27-45A-8 |
---|
822 | 822 | | With respect to a covered individual, Aa pharmacy |
---|
823 | 823 | | benefits manager , directly or through an affiliate or a |
---|
824 | 824 | | contracted third party, may not do any of the following: |
---|
825 | 825 | | (1) Require a covered individual, as a condition of |
---|
826 | 826 | | payment or reimbursement, to purchase pharmacist services, |
---|
827 | 827 | | including, but not limited to, prescription drugs, exclusively |
---|
828 | 828 | | through a mail-order pharmacy or pharmacy benefits manager |
---|
829 | 829 | | affiliate. |
---|
830 | 830 | | (2) Prohibit or limit any covered individual from |
---|
831 | 831 | | selecting an in-network pharmacy or pharmacist of his or her |
---|
832 | 832 | | choice who meets and agrees to the terms and conditions, |
---|
833 | 833 | | including reimbursements, in the pharmacy benefits manager's |
---|
834 | 834 | | contract. |
---|
835 | 835 | | (3) Impose a monetary advantage or penalty under a |
---|
836 | 836 | | health benefit plan that would affect a covered individual's |
---|
837 | 837 | | choice of pharmacy among those pharmacies that have chosen to |
---|
838 | 838 | | contract with the pharmacy benefits manager under the same |
---|
839 | 839 | | terms and conditions, including reimbursements. For purposes |
---|
840 | 840 | | of this subdivision, "monetary advantage or penalty" includes, |
---|
841 | 841 | | but is not limited to, a higher copayment, a waiver of a |
---|
842 | 842 | | copayment, a reduction in reimbursement services, a |
---|
843 | 843 | | requirement or limit on the number of days of a drug supply |
---|
844 | 844 | | for which reimbursement will be allowed, or a promotion of one |
---|
845 | 845 | | participating pharmacy over another by these methods. |
---|
846 | 846 | | (4)a. Use a covered individual's pharmacy services data |
---|
847 | 847 | | collected pursuant to the provision of claims processing |
---|
848 | 848 | | services for the purpose of soliciting, marketing, or |
---|
849 | 849 | | 393 |
---|
850 | 850 | | 394 |
---|
851 | 851 | | 395 |
---|
852 | 852 | | 396 |
---|
853 | 853 | | 397 |
---|
854 | 854 | | 398 |
---|
855 | 855 | | 399 |
---|
856 | 856 | | 400 |
---|
857 | 857 | | 401 |
---|
858 | 858 | | 402 |
---|
859 | 859 | | 403 |
---|
860 | 860 | | 404 |
---|
861 | 861 | | 405 |
---|
862 | 862 | | 406 |
---|
863 | 863 | | 407 |
---|
864 | 864 | | 408 |
---|
865 | 865 | | 409 |
---|
866 | 866 | | 410 |
---|
867 | 867 | | 411 |
---|
868 | 868 | | 412 |
---|
869 | 869 | | 413 |
---|
870 | 870 | | 414 |
---|
871 | 871 | | 415 |
---|
872 | 872 | | 416 |
---|
873 | 873 | | 417 |
---|
874 | 874 | | 418 |
---|
875 | 875 | | 419 |
---|
876 | 876 | | 420 HB238 INTRODUCED |
---|
877 | 877 | | Page 16 |
---|
878 | 878 | | services for the purpose of soliciting, marketing, or |
---|
879 | 879 | | referring the covered individual to a mail-order pharmacy or |
---|
880 | 880 | | PBM affiliate. |
---|
881 | 881 | | b. This subdivision shall not limit a health benefit |
---|
882 | 882 | | plan's use of pharmacy services data for the purpose of |
---|
883 | 883 | | administering the health benefit plan. |
---|
884 | 884 | | c. This subdivision shall not prohibit a pharmacy |
---|
885 | 885 | | benefits manager from notifying a covered individual that a |
---|
886 | 886 | | less costly option for a specific prescription drug is |
---|
887 | 887 | | available through a mail-order pharmacy or PBM affiliate, |
---|
888 | 888 | | provided the notification shall state that switching to the |
---|
889 | 889 | | less costly option is not mandatory. The commissioner, by |
---|
890 | 890 | | rule, may determine the language of the notification |
---|
891 | 891 | | authorized under this paragraph made by a pharmacy benefits |
---|
892 | 892 | | manager to a covered individual. |
---|
893 | 893 | | (5) Require a covered individual to make a payment for |
---|
894 | 894 | | a prescription drug at the point of sale in an amount that |
---|
895 | 895 | | exceeds the lessorlesser of the following: |
---|
896 | 896 | | a. The contracted cost share amount. |
---|
897 | 897 | | b. An amount an individual would pay for a prescription |
---|
898 | 898 | | if that individual were paying without insurance. |
---|
899 | 899 | | (6) Charge a covered individual a copayment or a |
---|
900 | 900 | | cost-sharing amount that is greater than the amount paid to |
---|
901 | 901 | | the pharmacy that dispenses the prescription drug. " |
---|
902 | 902 | | "§27-45A-9 |
---|
903 | 903 | | (a) For purposes of this section, client "client" means |
---|
904 | 904 | | a health insurer, payor, or health benefit plan. |
---|
905 | 905 | | (b) If requested by a client under subsection (d), a |
---|
906 | 906 | | pharmacy benefits manager shall prepare an annual report by |
---|
907 | 907 | | 421 |
---|
908 | 908 | | 422 |
---|
909 | 909 | | 423 |
---|
910 | 910 | | 424 |
---|
911 | 911 | | 425 |
---|
912 | 912 | | 426 |
---|
913 | 913 | | 427 |
---|
914 | 914 | | 428 |
---|
915 | 915 | | 429 |
---|
916 | 916 | | 430 |
---|
917 | 917 | | 431 |
---|
918 | 918 | | 432 |
---|
919 | 919 | | 433 |
---|
920 | 920 | | 434 |
---|
921 | 921 | | 435 |
---|
922 | 922 | | 436 |
---|
923 | 923 | | 437 |
---|
924 | 924 | | 438 |
---|
925 | 925 | | 439 |
---|
926 | 926 | | 440 |
---|
927 | 927 | | 441 |
---|
928 | 928 | | 442 |
---|
929 | 929 | | 443 |
---|
930 | 930 | | 444 |
---|
931 | 931 | | 445 |
---|
932 | 932 | | 446 |
---|
933 | 933 | | 447 |
---|
934 | 934 | | 448 HB238 INTRODUCED |
---|
935 | 935 | | Page 17 |
---|
936 | 936 | | pharmacy benefits manager shall prepare an annual report by |
---|
937 | 937 | | June 1 which discloses all of the following with respect to |
---|
938 | 938 | | that client: |
---|
939 | 939 | | (1) Thethe aggregate amount of all rebates that the |
---|
940 | 940 | | pharmacy benefits manager received from pharmaceutical |
---|
941 | 941 | | manufacturers on behalf of the client. |
---|
942 | 942 | | (2) The aggregate amount of the rebates the pharmacy |
---|
943 | 943 | | benefits manager received from pharmaceutical manufacturers |
---|
944 | 944 | | that did not pass through to the client. |
---|
945 | 945 | | (3) If a pharmacy benefits manager or any consultant |
---|
946 | 946 | | providing pharmacy benefits management services engages in |
---|
947 | 947 | | spread pricing, the aggregated amount of the difference |
---|
948 | 948 | | between the amount paid by the client for prescription drugs |
---|
949 | 949 | | and the actual amount paid to the pharmacy or pharmacist for |
---|
950 | 950 | | pharmacist services. For purposes of this subdivision, "spread |
---|
951 | 951 | | pricing" means the model of prescription drug reimbursement in |
---|
952 | 952 | | which a pharmacy benefits manager charges a client a |
---|
953 | 953 | | contracted price for prescription drugs, and the contract |
---|
954 | 954 | | price for the prescription drugs differs from the amount the |
---|
955 | 955 | | pharmacy benefits manager, directly or indirectly, pays the |
---|
956 | 956 | | pharmacy or pharmacist for pharmacist services. |
---|
957 | 957 | | (c) Confidentiality of a report submitted under this |
---|
958 | 958 | | section shall be governed by contract between the pharmacy |
---|
959 | 959 | | benefits manager and the client. |
---|
960 | 960 | | (d) A pharmacy benefits manager shall annually notify |
---|
961 | 961 | | all its clients in a timely manner that a report described in |
---|
962 | 962 | | subsection (b) will be made available to the client by the |
---|
963 | 963 | | pharmacy benefits manager if requested by the client." |
---|
964 | 964 | | "§27-45A-10 |
---|
965 | 965 | | 449 |
---|
966 | 966 | | 450 |
---|
967 | 967 | | 451 |
---|
968 | 968 | | 452 |
---|
969 | 969 | | 453 |
---|
970 | 970 | | 454 |
---|
971 | 971 | | 455 |
---|
972 | 972 | | 456 |
---|
973 | 973 | | 457 |
---|
974 | 974 | | 458 |
---|
975 | 975 | | 459 |
---|
976 | 976 | | 460 |
---|
977 | 977 | | 461 |
---|
978 | 978 | | 462 |
---|
979 | 979 | | 463 |
---|
980 | 980 | | 464 |
---|
981 | 981 | | 465 |
---|
982 | 982 | | 466 |
---|
983 | 983 | | 467 |
---|
984 | 984 | | 468 |
---|
985 | 985 | | 469 |
---|
986 | 986 | | 470 |
---|
987 | 987 | | 471 |
---|
988 | 988 | | 472 |
---|
989 | 989 | | 473 |
---|
990 | 990 | | 474 |
---|
991 | 991 | | 475 |
---|
992 | 992 | | 476 HB238 INTRODUCED |
---|
993 | 993 | | Page 18 |
---|
994 | 994 | | "§27-45A-10 |
---|
995 | 995 | | (a) With respect to a pharmacist or pharmacy, Aa |
---|
996 | 996 | | pharmacy benefits manager , directly or through an affiliate or |
---|
997 | 997 | | a contracted third party, may not do any of the following: |
---|
998 | 998 | | (1) Reimburse an in-network pharmacy or pharmacist in |
---|
999 | 999 | | the state an amount less than the amount that the pharmacy |
---|
1000 | 1000 | | benefits manager reimburses a similarly situated PBM affiliate |
---|
1001 | 1001 | | for providing the same pharmacist services to covered |
---|
1002 | 1002 | | individuals in the same health benefit plan. |
---|
1003 | 1003 | | (2) Reimburse an in-network pharmacy for a prescription |
---|
1004 | 1004 | | drug in an amount that is less than or exceeds the actual |
---|
1005 | 1005 | | acquisition cost to the pharmacy for the prescription drug |
---|
1006 | 1006 | | plus a professional dispensing fee that is equal to the |
---|
1007 | 1007 | | professional dispensing fee paid by the state under Title XIX |
---|
1008 | 1008 | | of the Social Security Act. |
---|
1009 | 1009 | | (3) Practice spread pricing in this state. |
---|
1010 | 1010 | | (2)(4) Deny a pharmacy or pharmacist the right to |
---|
1011 | 1011 | | participate as a contractnetwork provider if the pharmacy or |
---|
1012 | 1012 | | pharmacist meets and agrees to the terms and conditions, |
---|
1013 | 1013 | | including reimbursements, in the pharmacy benefits manager's |
---|
1014 | 1014 | | contract. |
---|
1015 | 1015 | | (3)(5) Impose credentialing standards on a pharmacist |
---|
1016 | 1016 | | or pharmacy beyond or more onerous than the licensing |
---|
1017 | 1017 | | standards set by the Alabama State Board of Pharmacy or charge |
---|
1018 | 1018 | | a pharmacy a fee in connection with network enrollment, |
---|
1019 | 1019 | | provided this subdivision shall not prohibit a pharmacy |
---|
1020 | 1020 | | benefits manager from setting minimum requirements for |
---|
1021 | 1021 | | participating in a pharmacy network. |
---|
1022 | 1022 | | (4)(6) Prohibit a pharmacist or pharmacy from providing |
---|
1023 | 1023 | | 477 |
---|
1024 | 1024 | | 478 |
---|
1025 | 1025 | | 479 |
---|
1026 | 1026 | | 480 |
---|
1027 | 1027 | | 481 |
---|
1028 | 1028 | | 482 |
---|
1029 | 1029 | | 483 |
---|
1030 | 1030 | | 484 |
---|
1031 | 1031 | | 485 |
---|
1032 | 1032 | | 486 |
---|
1033 | 1033 | | 487 |
---|
1034 | 1034 | | 488 |
---|
1035 | 1035 | | 489 |
---|
1036 | 1036 | | 490 |
---|
1037 | 1037 | | 491 |
---|
1038 | 1038 | | 492 |
---|
1039 | 1039 | | 493 |
---|
1040 | 1040 | | 494 |
---|
1041 | 1041 | | 495 |
---|
1042 | 1042 | | 496 |
---|
1043 | 1043 | | 497 |
---|
1044 | 1044 | | 498 |
---|
1045 | 1045 | | 499 |
---|
1046 | 1046 | | 500 |
---|
1047 | 1047 | | 501 |
---|
1048 | 1048 | | 502 |
---|
1049 | 1049 | | 503 |
---|
1050 | 1050 | | 504 HB238 INTRODUCED |
---|
1051 | 1051 | | Page 19 |
---|
1052 | 1052 | | (4)(6) Prohibit a pharmacist or pharmacy from providing |
---|
1053 | 1053 | | a covered individual specific information on the amount of the |
---|
1054 | 1054 | | covered individual's cost share for the covered individual's |
---|
1055 | 1055 | | prescription drug , the acquisition cost and reimbursement |
---|
1056 | 1056 | | amount for the prescription drug, and the clinical efficacy of |
---|
1057 | 1057 | | a more affordable alternative drug or therapy if one is |
---|
1058 | 1058 | | available, or penalize a pharmacist or pharmacy for disclosing |
---|
1059 | 1059 | | this information to a covered individual as deemed necessary |
---|
1060 | 1060 | | in the professional judgment of the pharmacist or for selling |
---|
1061 | 1061 | | to a covered individual a more affordable alternative if one |
---|
1062 | 1062 | | is available in the completion of a business transaction . |
---|
1063 | 1063 | | (5)(7) Prohibit a pharmacist or pharmacy from offering |
---|
1064 | 1064 | | and providing delivery services to a covered individual as an |
---|
1065 | 1065 | | ancillary service of the pharmacy, provided all of the |
---|
1066 | 1066 | | following requirements are met: |
---|
1067 | 1067 | | a. The pharmacist or pharmacy can demonstrate quality, |
---|
1068 | 1068 | | stability, and safety standards during delivery. |
---|
1069 | 1069 | | b. The pharmacist or pharmacy does not charge any |
---|
1070 | 1070 | | delivery or service fee to a pharmacy benefits manager or |
---|
1071 | 1071 | | health insurer. |
---|
1072 | 1072 | | c. The pharmacist or pharmacy alerts the covered |
---|
1073 | 1073 | | individual that he or she will be responsible for any delivery |
---|
1074 | 1074 | | service fee associated with the delivery service, and that the |
---|
1075 | 1075 | | pharmacy benefits manager or health insurer will not reimburse |
---|
1076 | 1076 | | the delivery service fee. |
---|
1077 | 1077 | | (6)(8) Charge or hold a pharmacist or pharmacy |
---|
1078 | 1078 | | responsible for a fee or penalty relating to an audit |
---|
1079 | 1079 | | conducted pursuant to The Pharmacy Audit Integrity Act, |
---|
1080 | 1080 | | Article 8 of Chapter 23 of Title 34, provided this prohibition |
---|
1081 | 1081 | | 505 |
---|
1082 | 1082 | | 506 |
---|
1083 | 1083 | | 507 |
---|
1084 | 1084 | | 508 |
---|
1085 | 1085 | | 509 |
---|
1086 | 1086 | | 510 |
---|
1087 | 1087 | | 511 |
---|
1088 | 1088 | | 512 |
---|
1089 | 1089 | | 513 |
---|
1090 | 1090 | | 514 |
---|
1091 | 1091 | | 515 |
---|
1092 | 1092 | | 516 |
---|
1093 | 1093 | | 517 |
---|
1094 | 1094 | | 518 |
---|
1095 | 1095 | | 519 |
---|
1096 | 1096 | | 520 |
---|
1097 | 1097 | | 521 |
---|
1098 | 1098 | | 522 |
---|
1099 | 1099 | | 523 |
---|
1100 | 1100 | | 524 |
---|
1101 | 1101 | | 525 |
---|
1102 | 1102 | | 526 |
---|
1103 | 1103 | | 527 |
---|
1104 | 1104 | | 528 |
---|
1105 | 1105 | | 529 |
---|
1106 | 1106 | | 530 |
---|
1107 | 1107 | | 531 |
---|
1108 | 1108 | | 532 HB238 INTRODUCED |
---|
1109 | 1109 | | Page 20 |
---|
1110 | 1110 | | Article 8 of Chapter 23 of Title 34, provided this prohibition |
---|
1111 | 1111 | | does not restrict recoupments made in accordance with the |
---|
1112 | 1112 | | Pharmacy Audit Integrity Act that article. |
---|
1113 | 1113 | | (7)(9) Charge a pharmacist or pharmacy a point-of-sale |
---|
1114 | 1114 | | or retroactive fee or otherwise recoup funds from a pharmacy |
---|
1115 | 1115 | | in connection with claims for which the pharmacy has already |
---|
1116 | 1116 | | been paid, unless the recoupment is made pursuant to an audit |
---|
1117 | 1117 | | conducted in accordance with the Pharmacy Audit Integrity |
---|
1118 | 1118 | | ActArticle 8 of Chapter 23 of Title 34 . |
---|
1119 | 1119 | | (10) Charge a pharmacy a fee in regard to enrollment, |
---|
1120 | 1120 | | credentialing or re-credentialing, change of ownership, |
---|
1121 | 1121 | | submission of claims, adjudication of claims, or otherwise if |
---|
1122 | 1122 | | not in conjunction with an audit conducted pursuant to Article |
---|
1123 | 1123 | | 8 of Chapter 23 of Title 34. |
---|
1124 | 1124 | | (11) Initiate a fraud, waste, or abuse investigation |
---|
1125 | 1125 | | without first notifying the pharmacist or pharmacy and |
---|
1126 | 1126 | | receiving approval from the commissioner on the basis of |
---|
1127 | 1127 | | information that supports an articulable suspicion of fraud, |
---|
1128 | 1128 | | waste, or abuse by the pharmacist or pharmacy to be |
---|
1129 | 1129 | | investigated. |
---|
1130 | 1130 | | (12) Impose additional terms on a pharmacy unless the |
---|
1131 | 1131 | | pharmacy or its representative agrees to the terms in writing. |
---|
1132 | 1132 | | (8)(b)(1) Except for a drug reimbursed, directly or |
---|
1133 | 1133 | | indirectly, by the Medicaid program, a pharmacy benefits |
---|
1134 | 1134 | | manager may not vary the amount athe pharmacy benefits manager |
---|
1135 | 1135 | | reimburses an entity for a drug, including each and every |
---|
1136 | 1136 | | prescription medication that is eligible for specialty tier |
---|
1137 | 1137 | | placement by the Centers for Medicare and Medicaid Services |
---|
1138 | 1138 | | pursuant to 42 C.F.R. § 423.560, regardless of any provision |
---|
1139 | 1139 | | 533 |
---|
1140 | 1140 | | 534 |
---|
1141 | 1141 | | 535 |
---|
1142 | 1142 | | 536 |
---|
1143 | 1143 | | 537 |
---|
1144 | 1144 | | 538 |
---|
1145 | 1145 | | 539 |
---|
1146 | 1146 | | 540 |
---|
1147 | 1147 | | 541 |
---|
1148 | 1148 | | 542 |
---|
1149 | 1149 | | 543 |
---|
1150 | 1150 | | 544 |
---|
1151 | 1151 | | 545 |
---|
1152 | 1152 | | 546 |
---|
1153 | 1153 | | 547 |
---|
1154 | 1154 | | 548 |
---|
1155 | 1155 | | 549 |
---|
1156 | 1156 | | 550 |
---|
1157 | 1157 | | 551 |
---|
1158 | 1158 | | 552 |
---|
1159 | 1159 | | 553 |
---|
1160 | 1160 | | 554 |
---|
1161 | 1161 | | 555 |
---|
1162 | 1162 | | 556 |
---|
1163 | 1163 | | 557 |
---|
1164 | 1164 | | 558 |
---|
1165 | 1165 | | 559 |
---|
1166 | 1166 | | 560 HB238 INTRODUCED |
---|
1167 | 1167 | | Page 21 |
---|
1168 | 1168 | | pursuant to 42 C.F.R. § 423.560, regardless of any provision |
---|
1169 | 1169 | | of law to the contrary, on the basis of whether: |
---|
1170 | 1170 | | a. The drug is subject to an agreement under 42 U.S.C. |
---|
1171 | 1171 | | § 256b; or |
---|
1172 | 1172 | | b. The entity participates in the program set forth in |
---|
1173 | 1173 | | 42 U.S.C. § 256b. |
---|
1174 | 1174 | | (9)(2) If an entity participates, directly or |
---|
1175 | 1175 | | indirectly, in the program set forth in 42 U.S.C. § 256b, a |
---|
1176 | 1176 | | pharmacy benefits manager may not do any of the following: |
---|
1177 | 1177 | | a. Assess a fee, charge-back, or other adjustment on |
---|
1178 | 1178 | | the entity. |
---|
1179 | 1179 | | b. Restrict access to the pharmacy benefits manager's |
---|
1180 | 1180 | | pharmacy network. |
---|
1181 | 1181 | | c. Require the entity to enter into a contract with a |
---|
1182 | 1182 | | specific pharmacy to participate in the pharmacy benefits |
---|
1183 | 1183 | | manager's pharmacy network. |
---|
1184 | 1184 | | d. Create a restriction or an additional charge on a |
---|
1185 | 1185 | | patient who chooses to receive drugs from the entity. |
---|
1186 | 1186 | | e. Create any additional requirements or restrictions |
---|
1187 | 1187 | | on the entity. |
---|
1188 | 1188 | | (10)(3)A pharmacy benefits manager may not |
---|
1189 | 1189 | | Requirerequire a claim for a drug to include a modifier to |
---|
1190 | 1190 | | indicate that the drug is subject to an agreement under 42 |
---|
1191 | 1191 | | U.S.C. § 256b. |
---|
1192 | 1192 | | (11)(c) A pharmacy benefits manager may not |
---|
1193 | 1193 | | Penalizepenalize or retaliate against a pharmacist or pharmacy |
---|
1194 | 1194 | | for exercising rights under this chapter or the Pharmacy Audit |
---|
1195 | 1195 | | Integrity ActArticle 8 of Chapter 23 of Title 34 ." |
---|
1196 | 1196 | | Section 2. Section 27-45A-13 is added to the Code of |
---|
1197 | 1197 | | 561 |
---|
1198 | 1198 | | 562 |
---|
1199 | 1199 | | 563 |
---|
1200 | 1200 | | 564 |
---|
1201 | 1201 | | 565 |
---|
1202 | 1202 | | 566 |
---|
1203 | 1203 | | 567 |
---|
1204 | 1204 | | 568 |
---|
1205 | 1205 | | 569 |
---|
1206 | 1206 | | 570 |
---|
1207 | 1207 | | 571 |
---|
1208 | 1208 | | 572 |
---|
1209 | 1209 | | 573 |
---|
1210 | 1210 | | 574 |
---|
1211 | 1211 | | 575 |
---|
1212 | 1212 | | 576 |
---|
1213 | 1213 | | 577 |
---|
1214 | 1214 | | 578 |
---|
1215 | 1215 | | 579 |
---|
1216 | 1216 | | 580 |
---|
1217 | 1217 | | 581 |
---|
1218 | 1218 | | 582 |
---|
1219 | 1219 | | 583 |
---|
1220 | 1220 | | 584 |
---|
1221 | 1221 | | 585 |
---|
1222 | 1222 | | 586 |
---|
1223 | 1223 | | 587 |
---|
1224 | 1224 | | 588 HB238 INTRODUCED |
---|
1225 | 1225 | | Page 22 |
---|
1226 | 1226 | | Section 2. Section 27-45A-13 is added to the Code of |
---|
1227 | 1227 | | Alabama 1975, to read as follows: |
---|
1228 | 1228 | | §27-45A-13 |
---|
1229 | 1229 | | (a) For the purposes of this section, the following |
---|
1230 | 1230 | | terms have the following meanings: |
---|
1231 | 1231 | | (1) CLIENT. A health insurer or a payor. |
---|
1232 | 1232 | | (2) PHARMACY BENEFIT. The part of a health benefit plan |
---|
1233 | 1233 | | that reimburses for pharmacist services, including |
---|
1234 | 1234 | | prescription drugs and devices. |
---|
1235 | 1235 | | (b) A pharmacy benefits manager, directly or through an |
---|
1236 | 1236 | | affiliate or contracted third party, shall pass on to a client |
---|
1237 | 1237 | | 100 percent of all rebates the pharmacy benefits manager |
---|
1238 | 1238 | | receives, directly or indirectly, from pharmaceutical |
---|
1239 | 1239 | | manufacturers in connection with claims the pharmacy benefits |
---|
1240 | 1240 | | manager administers on behalf of the client's health benefit |
---|
1241 | 1241 | | plan unless the client directs the pharmacy benefits manager |
---|
1242 | 1242 | | to apply the rebates to purchases of prescription drugs by |
---|
1243 | 1243 | | covered individuals at the point-of-sale. Notwithstanding the |
---|
1244 | 1244 | | foregoing, nothing shall be construed to allow a rebate from a |
---|
1245 | 1245 | | pharmaceutical manufacturer, directly or indirectly, to a |
---|
1246 | 1246 | | pharmacy benefits manager, or its PBM affiliate, or its client |
---|
1247 | 1247 | | where otherwise prohibited by law. |
---|
1248 | 1248 | | (c) When a client makes a written request to a pharmacy |
---|
1249 | 1249 | | benefits manager to reassign or transfer a pharmacy benefit to |
---|
1250 | 1250 | | another pharmacy benefits manager, within 30 days, the |
---|
1251 | 1251 | | pharmacy benefits manager, directly or through an affiliate or |
---|
1252 | 1252 | | contracted third party, shall do both of the following: |
---|
1253 | 1253 | | (1) Provide the client with the prescription drug file. |
---|
1254 | 1254 | | (2) Establish all electronic data interchange (EDI) |
---|
1255 | 1255 | | 589 |
---|
1256 | 1256 | | 590 |
---|
1257 | 1257 | | 591 |
---|
1258 | 1258 | | 592 |
---|
1259 | 1259 | | 593 |
---|
1260 | 1260 | | 594 |
---|
1261 | 1261 | | 595 |
---|
1262 | 1262 | | 596 |
---|
1263 | 1263 | | 597 |
---|
1264 | 1264 | | 598 |
---|
1265 | 1265 | | 599 |
---|
1266 | 1266 | | 600 |
---|
1267 | 1267 | | 601 |
---|
1268 | 1268 | | 602 |
---|
1269 | 1269 | | 603 |
---|
1270 | 1270 | | 604 |
---|
1271 | 1271 | | 605 |
---|
1272 | 1272 | | 606 |
---|
1273 | 1273 | | 607 |
---|
1274 | 1274 | | 608 |
---|
1275 | 1275 | | 609 |
---|
1276 | 1276 | | 610 |
---|
1277 | 1277 | | 611 |
---|
1278 | 1278 | | 612 |
---|
1279 | 1279 | | 613 |
---|
1280 | 1280 | | 614 |
---|
1281 | 1281 | | 615 |
---|
1282 | 1282 | | 616 HB238 INTRODUCED |
---|
1283 | 1283 | | Page 23 |
---|
1284 | 1284 | | (2) Establish all electronic data interchange (EDI) |
---|
1285 | 1285 | | connections necessary for the client to transfer the pharmacy |
---|
1286 | 1286 | | benefit to the new pharmacy benefits manager and maintain the |
---|
1287 | 1287 | | EDI for the six-month period following the transfer of the |
---|
1288 | 1288 | | pharmacy benefit. |
---|
1289 | 1289 | | (d) A pharmacy benefits manager, directly or through a |
---|
1290 | 1290 | | PBM affiliate or contracted party, may not do any of the |
---|
1291 | 1291 | | following: |
---|
1292 | 1292 | | (1) Engage in spread pricing. |
---|
1293 | 1293 | | (2) Charge a client more for a drug at a pharmacy |
---|
1294 | 1294 | | affiliated with the pharmacy benefits manager than the actual |
---|
1295 | 1295 | | acquisition cost for the ingredient cost of the drug. |
---|
1296 | 1296 | | (3) Enter into any agreement with a client which |
---|
1297 | 1297 | | defines "rebate" more narrowly than the definition in this |
---|
1298 | 1298 | | article or that in any way circumvents the requirement of this |
---|
1299 | 1299 | | section to pass 100 percent of the rebates back to the client. |
---|
1300 | 1300 | | (4) Enter into any agreement with a pharmaceutical |
---|
1301 | 1301 | | manufacturer that, directly or indirectly, allocates rebates |
---|
1302 | 1302 | | earned under one health benefit plan to a different health |
---|
1303 | 1303 | | benefit plan. |
---|
1304 | 1304 | | (5) Enter any agreement with a pharmaceutical |
---|
1305 | 1305 | | manufacturer for a rebate that is not attributable to a |
---|
1306 | 1306 | | specific drug covered under a specific health benefit plan. |
---|
1307 | 1307 | | (6) Charge a client a fee for access to a prescription |
---|
1308 | 1308 | | drug file that exceeds the pharmacy benefits manager's |
---|
1309 | 1309 | | reasonable cost of providing access. |
---|
1310 | 1310 | | (7) Deny or delay or take any action calculated to |
---|
1311 | 1311 | | inhibit the transfer of a prescription drug file to a client |
---|
1312 | 1312 | | when the client requests the transfer of the file. |
---|
1313 | 1313 | | 617 |
---|
1314 | 1314 | | 618 |
---|
1315 | 1315 | | 619 |
---|
1316 | 1316 | | 620 |
---|
1317 | 1317 | | 621 |
---|
1318 | 1318 | | 622 |
---|
1319 | 1319 | | 623 |
---|
1320 | 1320 | | 624 |
---|
1321 | 1321 | | 625 |
---|
1322 | 1322 | | 626 |
---|
1323 | 1323 | | 627 |
---|
1324 | 1324 | | 628 |
---|
1325 | 1325 | | 629 |
---|
1326 | 1326 | | 630 |
---|
1327 | 1327 | | 631 |
---|
1328 | 1328 | | 632 |
---|
1329 | 1329 | | 633 |
---|
1330 | 1330 | | 634 |
---|
1331 | 1331 | | 635 |
---|
1332 | 1332 | | 636 |
---|
1333 | 1333 | | 637 |
---|
1334 | 1334 | | 638 |
---|
1335 | 1335 | | 639 |
---|
1336 | 1336 | | 640 |
---|
1337 | 1337 | | 641 |
---|
1338 | 1338 | | 642 |
---|
1339 | 1339 | | 643 |
---|
1340 | 1340 | | 644 HB238 INTRODUCED |
---|
1341 | 1341 | | Page 24 |
---|
1342 | 1342 | | when the client requests the transfer of the file. |
---|
1343 | 1343 | | (8) Take any action calculated to penalize a client for |
---|
1344 | 1344 | | switching to a new pharmacy benefits manager, including, but |
---|
1345 | 1345 | | not limited to, charging the prospective pharmacy benefits |
---|
1346 | 1346 | | manager a fee to access the prescription drug file or |
---|
1347 | 1347 | | withholding rebates due to a client which are earned during |
---|
1348 | 1348 | | the period before an agreement with the new pharmacy benefits |
---|
1349 | 1349 | | manager takes effect. |
---|
1350 | 1350 | | (9) Contract with any party, including a health insurer |
---|
1351 | 1351 | | or third-party administrator, that engages in any of the |
---|
1352 | 1352 | | practices prohibited in this section. |
---|
1353 | 1353 | | Section 3. Section 34-23-187, Code of Alabama 1975, is |
---|
1354 | 1354 | | amended to read as follows: |
---|
1355 | 1355 | | "§34-23-187 |
---|
1356 | 1356 | | This article does not shall apply to any audit, review, |
---|
1357 | 1357 | | or investigation that involves alleged fraud, willful |
---|
1358 | 1358 | | misrepresentation, or waste abuse that is initiated by a |
---|
1359 | 1359 | | pharmacy benefits manager ." |
---|
1360 | 1360 | | Section 4. This act shall become effective on October |
---|
1361 | 1361 | | 1, 2024. |
---|
1362 | 1362 | | 645 |
---|
1363 | 1363 | | 646 |
---|
1364 | 1364 | | 647 |
---|
1365 | 1365 | | 648 |
---|
1366 | 1366 | | 649 |
---|
1367 | 1367 | | 650 |
---|
1368 | 1368 | | 651 |
---|
1369 | 1369 | | 652 |
---|
1370 | 1370 | | 653 |
---|
1371 | 1371 | | 654 |
---|
1372 | 1372 | | 655 |
---|
1373 | 1373 | | 656 |
---|
1374 | 1374 | | 657 |
---|
1375 | 1375 | | 658 |
---|
1376 | 1376 | | 659 |
---|
1377 | 1377 | | 660 |
---|
1378 | 1378 | | 661 |
---|
1379 | 1379 | | 662 |
---|
1380 | 1380 | | 663 |
---|